ReviewTherapeutic advances in medical oncology2014
The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers.
Elisavet Paplomata et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
329 papers cite itlatest 60 shown
this paperpooled ittrialcites it